On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Gladstone discoveries compete head-to-head with other scientific advancements
Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab ChaturvediGladstone investigator receives distinct honor within the scientific community
Awards News Release Neurological Disease Akassoglou LabGladstone scientist receives highest distinction for academic inventors
Awards News Release Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Akassoglou Lab